Lubomir Bodnar

10PUBLICATIONS
47CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyBiologically active moleculesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 04, 2026
PARP Inhibitors and the Risk of Serum Creatinine Elevation in Ovarian Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

|Mar 14, 2026
Real-World Outcomes of Primary Versus Interval Debulking Surgery in a Multicenter Cohort of Advanced Ovarian Cancer Patients Treated with Bevacizumab.

Kaja Michalczyk, Lubomir Bodnar, Marta Czeluścińska-Murawiec

|Jun 25, 2025
Updated Guidelines for the Diagnosis and Treatment of Endometrial Carcinoma: The Polish Society of Gynecological Oncology (2025v).

Jacek J Sznurkowski, Lubomir Bodnar, Anna Dańska-Bidzińska

|Jun 18, 2025
Adoptive cell therapy with macrophage-drug conjugates facilitates cytotoxic drug transfer and immune activation in glioblastoma models.

Miaomiao Sun, Maciej Bialasek, Maud Mayoux

|Feb 03, 2025
Harnessing macrophage-drug conjugates for allogeneic cell-based therapy of solid tumors via the TRAIN mechanism.

Bartlomiej Taciak, Maciej Bialasek, Malgorzata Kubiak

|Jul 29, 2023
The Effect of Acetylsalicylic Acid, as a Representative Non-Steroidal Anti-Inflammatory Drug, on the Activity of Myeloperoxidase.

Beata Gąsowska-Bajger, Kinga Sosnowska, Agnieszka Gąsowska-Bodnar

Pageof 2

Frequent Collaborators

2 joint publications

Tobias Weiss

2 joint publications

Tomasz P Rygiel

2 joint publications

Jan Brancewicz

2 joint publications

Magdalena Krol